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Exposure to toxic metals is a health hazard 
throughout the world today. In addition to 
lead and mercury, cadmium has been identi-
fied as one of the most probable causes of dis-
ease related to heavy metal exposure observed 
in primary care medicine (Hu 2000). Both 
animal experiments and epidemiologic studies 
have confirmed that cadmium is toxic to kid-
ney, liver, bone, and gonads and causes cancer 
(Alfven et al. 2002; Buchet et al. 1990; Mandel 
et al. 1995; Parizek and Zahor 1956; Rikans 
and Yamano 2000). The Agency for Toxic 
Substances and Disease Registry (ATSDR) has 
listed cadmium among the top seven of the 
275 most hazardous substances in the environ-
ment (ATSDR 1999). The placenta acts as a 
barrier for cadmium, in contrast to lead and 
mercury, and very little cadmium (< 10%) is 
transferred to the fetus (Osman et al. 2000). 
Also, the transfer of cadmium to milk is low 
(Hallen et al. 1995). Thus, the fetus and the 
newborn are protected against cadmium. 
Cadmium exposure, however, can start at a 
very young age. The main exposure sources 
for children are food, environmental tobacco 
smoke, and house dust. Cadmium can enter 
the blood by absorption from the stomach 
or intestines after ingestion of food or water 
or by absorption from the lungs after inhala-
tion. Approximately 50% of total body stores 
are in the liver and kidney (Pope and Rall 
1995). Once cadmium enters the body, it has 
a biological half-life of 10–30 years in kidney 
and 5–10 years in liver [U.S. Environmental 
Protection Agency (EPA) 1997; International 
Programme on Chemical Safety 1992]. The 
main effects of chronic cadmium toxicity, renal 
disease and bone loss, are related to cadmium 
concentration in the kidney and the conse-
quent alteration of renal function.
Animal experiments have reported neu-
rotoxic and behavioral effects of cadmium 
(Gupta et al. 1991). The neurotoxicity and 
developmental toxicity of cadmium were also 
observed in human children in several epide-
miologic studies conducted in the 1970s and 
1980s. In all of these studies, the biomarker of 
exposure was the concentration of cadmium in 
hair. In case–control studies, higher concentra-
tions of cadmium were reported in children 
with mental retardation (Jiang et al. 1990; 
Marlowe et al. 1983) and with learning dif-
ficulties or dyslexia (Capel et al. 1981; Pihl and 
Parkes 1977). A significant inverse relationship 
was described between in utero exposure to 
cadmium and lead and the child’s motor and 
perceptual abilities at 6 years of age (Bonithon-
Kopp et al. 1986). In a cohort study, the con-
centration of cadmium was inversely related to 
IQ (Thatcher et al. 1982). Other investigators 
reported associations between cadmium and 
children’s performance on verbal IQ and visu-
al-motor and cognitive tasks (ATSDR 1999; 
Marlowe et al. 1985b; Moon et al. 1985). 
However, these studies have received little 
attention, and it is not clear whether the effects 
described were due to exposure to cadmium or 
to other substances (i.e., lead exposure).
Effects of cadmium exposure on the car-
diovascular system and cadmium-induced 
hypertension have also been reported in human 
studies and animal models (Satarug et al. 2005, 
2006; Staessen et al. 1992), but epidemiologic 
studies are inconsistent. Although some stud-
ies found positive associations (McKenzie and 
Kay 1973; Pizent et al. 2001; Tellez-Plaza 
et al. 2008; Vivoli et al. 1989; Whittemore 
et al. 1991), other studies found null or even 
inverse associations (Beevers et al. 1976; 
Kagamimori et al. 1986; Staessen et al. 1984, 
1991; Telisman et al. 2001). Most of these 
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Ba c k g r o u n d: Adverse health effects of cadmium in adults are well documented, but little is known 
about the neuropsychological effects of cadmium in children, and no studies of cadmium and blood 
pressure in children have been conducted.
oB j e c t i v e: We examined the potential effects of low-level cadmium exposure on intelligence 
quotient, neuropsychological functions, behavior, and blood pressure among children, using blood 
cadmium as a measure of exposure.
Me t h o d s : We used the data from a multicenter randomized clinical trial of lead-exposed children 
and analyzed blood cadmium concentrations using the whole blood samples collected when children 
were 2 years of age. We compared neuropsychological and behavioral scores at 2, 5, and 7 years of 
age by cadmium level and analyzed the relationship between blood cadmium levels at 2 years of age 
and systolic and diastolic blood pressure at 2, 5, and 7 years of age.
re s u l t s: The average cadmium concentration of these children was 0.21 µg/L, lower than for 
adults in the National Health and Nutrition Examination Survey (NHANES), but comparable to 
concentrations in children < 3 years of age in NHANES. Except for the California Verbal Learning 
Test for Children, there were no differences in test scores among children in different cadmium 
categories. For children with detectable pretreatment blood cadmium, after adjusting for a variety 
of covariates, general linear model analyses showed that at none of the three age points was the coef-
ficient of cadmium on Mental Development Index or IQ statistically significant. Spline regression 
analysis suggested that behavioral problem scores at 5 and 7 years of age tended to increase with 
increasing blood cadmium, but the trend was not significant. We found no significant associations 
between blood cadmium levels and blood pressure.
co n c l u s i o n: We found no significant associations between background blood cadmium levels at 
2 years of age and neurodevelopmental end points and blood pressure at 2, 5, and 7 years of age. 
The neuropsychological or hypertensive effects from longer background exposures to cadmium need 
further study.
key w o r d s : behavior, blood pressure, cadmium, children, clinical trial, intelligence, neurodevelop-
ment. Environ Health Perspect 117:1580–1586 (2009).  doi:10.1289/ehp.0900765 available via 
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studies were limited by small sample sizes, lack 
of adjustment for potential confounders, no 
standardization of blood pressure measure-
ments, and other methodological constraints 
(Tellez-Plaza et al. 2008). No epidemiologic 
studies of cadmium and blood pressure in chil-
dren have been conducted to date.
The Treatment of Lead-Exposed Children 
(TLC) trial (Dietrich et al. 2004) provided a 
unique opportunity to examine several impor-
tant questions for the first time: the associa-
tions of cadmium with IQ, neuropsychological 
function, and behavior in children, using blood 
cadmium as a measure of exposure, and the 
association of cadmium with blood pressure in 
children from a large-scale study.
Subjects and Methods
Study design. The TLC study was a multi-
center, placebo-controlled, randomized 
clinical trial that examined the effect of suc-
cimer treatment on growth, behavior, and 
development of lead-exposed children in 
the United States. The study was conducted 
between September 1994 and June 2003 in 
Philadelphia, Pennsylvania; Newark, New 
Jersey; Cincinnati, Ohio; and Baltimore, 
Maryland. The study was approved by the 
institutional review boards (IRBs) at the clini-
cal sites, data coordinating center (Harvard 
University, Cambridge, MA, USA), and the 
National Institute of Environmental Health 
Sciences. TLC complied with all applicable 
U.S. regulations; written informed consent 
was obtained from all children’s parents or 
guardians. For the present study, we created 
an anonymized data set with no links to indi-
vidual identifiers but with clinical and devel-
opmental information linked to the samples. 
Analysis of those samples for cadmium and 
analysis of data using the results were declared 
exempt from further IRB clearance by the 
Office of Protection from Research Risks at 
the National Institutes of Health.
Children were eligible for the initial TLC 
visit if they were expected to be between 12 
and 33 months of age at randomization and 
had a referral blood lead level between 20 
and 44 µg/dL. A total of 780 children entered 
the randomization phase, with 396 children 
allocated to succimer (Chemet; McNeil 
Laboratories, Fort Washington, PA, USA) and 
384 allocated to placebo. Depending on the 
blood lead concentration, children in the suc-
cimer group could receive up to three 26-day 
courses of treatment; the number of courses 
given to placebo children was frequency-
matched to that in the succimer group. Blood 
samples were collected on days 7, 28, and 42 
after the beginning of each of three treatment 
courses, as well as at every 3 months through 
the 24-month posttreatment follow-up, and 
then every 4 months until 72 months of age 
or the end of the study. Details of the study 
design and participant flow of the TLC study 
have been published elsewhere (Dietrich et al. 
2004; TLC Trial Group 1998).
Neuropsychological and behavioral tests. 
Before treatment began, we administered 
the Bayley Scales of Infant Development-II 
(BSID-II) (Bayley 1993), the most widely used 
measure of infant intelligence. The Mental 
Development Index (MDI) of the BSID-II is 
analogous to an IQ score. After treatment, two 
waves of cognitive, behavioral, psychological, 
and developmental assessments were adminis-
tered at about 5 and 7 years of age. The child’s 
IQ was assessed with the Wechsler Preschool 
and Primary Scales of Intelligence–Revised 
(Wechsler 1989) and Wechsler Intelligence 
Scale for Children–III (Wechsler 1991) at 
5 and 7 years of age, respectively. The neu-
ropsychological and behavioral tests used at 
5 years of age included the Developmental 
Neuropsychological Assessment (NEPSY) 
(Korkman 1998) and Conners’ Parent Rating 
Scale–Revised(CPRS-R) (Conners 1997). At 7 
years of age, the NEPSY, Conners’ Continuous 
Performance Test (CPT) (Conners 1995), 
California Verbal Learning Test for Children 
(CVLTC) (Delis et al. 1994), Woodcock 
Language Proficiency Battery–Revised 
(WLPB-R) (Woodcock 1991), Neurologic 
Examination for Subtle Signs (NESS) (Denckla 
1985), Behavioral Assessment System for 
Children teacher rating scale (BASC-TRS), 
and BASC parent rating scale (BASC-PRS) 
(Reynolds and Kamphaus 1992) were admin-
istered. The detailed information of the use 
of these standardized instruments in the TLC 
have been described elsewhere (Dietrich et al. 
2004; Rogan et al. 2001).
Measurement of blood cadmium concen-
tration. The Division of Laboratory Sciences 
at the National Center for Environmental 
Health at Centers for Disease Control and 
Prevention (CDC) analyzed the total blood 
cadmium levels using samples drawn about 
1 week before randomization (pretreatment) 
and samples drawn 1 week after treatment 
began (posttreatment), which showed the 
largest mean difference between treatment 
groups in blood lead level. Whole blood spec-
imens were tested using inductively coupled 
plasma mass spectrometry (ICP-MS) (CDC 
2007). This multielement analytical technique 
is based on quadrupole ICP-MS technology 
(Date and Gray 1989). The limit of detection 
(LOD) of cadmium was 0.2 µg/L.
For cadmium analysis, National Institute 
of Standards and Technology (NIST) stan-
dard reference materials and two levels of in-
house blood pools traceable to the reference 
material were used for daily quality control.
One of two different levels of a blind quality 
control material was inserted in every analyti-
cal group of samples for an additional qual-
ity control check. NIST Standard Reference 
Material 966 (NIST, Gaithersburg, MD, 
USA) was analyzed periodically to ensure 
  analytical accuracy.
Blood pressure measurements. At each visit 
during the treatment courses and follow-up, 
study nurses measured systolic and diastolic 
blood pressures for children. A Dinamap 
Vital Signs Monitor (an automatic device; 
Critikon, Inc., Tampa, FL, USA) was used for 
all blood pressure measurements. Blood pres-
sure was measured when children were seated, 
and the average of up to three measurements 
per visit was used for statistical analysis (Chen 
et al. 2006).
Statistical analysis. Because > 40% of the 
pre- and posttreatment blood cadmium lev-
els were below the LOD, we treated them as 
heavily left-censored data to conduct sum-
mary analyses. Instead of simply replacing the 
nondetectable observations with LOD divided 
by the square root of 2, we read the nonde-
tectable values as being between zero and 
LOD (the “censoring interval”) and then used 
a maximum likelihood estimation method 
to estimate mean, percentiles, and variance. 
Censored data analyses were conducted with 
Minitab software (version 15.1; Minitab, 
Inc., State College, PA, USA). For geometric 
mean (GM) estimation, however, we used the 
method of replacing nondetectable values with 
LOD divided by the square root of 2. Samples 
not measured because of insufficient sample 
volume were excluded from all analyses.
The correlations between blood cadmium, 
blood lead, IQ, and behavioral indices were 
tested by nonparametric Kendall’s tau-b cor-
relation coefficient (ktau-b), which makes no 
assumption of linearity between variables and 
accommodates data sets with censored values 
(Helsel 2004).
To examine the associations between cad-
mium and neuropsychological functions, we 
grouped children into five categories based on 
the LOD of cadmium and the four quartiles 
of detectable pretreatment cadmium. The dif-
ferences of neuropsychological and behavioral 
test scores at 5 and 7 years of age across cad-
mium categories were compared by Dunnett’s 
two-tailed t-test, with the blood cadmium 
< LOD category as reference group.
Because the large percentage of censored 
data will distort the compliance for the dis-
tribution requirement, and because we would 
not expect an association between IQ and 
lower cadmium levels if there was no associa-
tion between IQ and higher cadmium levels, 
we further limited the analysis to the children 
with detectable blood cadmium and analyzed 
the relationships between cadmium exposure 
and IQ and behavioral test scores. In these 
children, the blood cadmium concentrations 
were lognormally distributed, so we used a 
logarithmic transformation of the exposure 
variable. We also examined the cadmium and Cao et al.
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IQ and behavior associations using scatter 
plots and cubic smoothing splines (which 
provided a fitted curve constructed by piece-
wise polynomials) with S-PLUS software 
(version 8.0; Insightful Corp, Seattle, WA, 
USA). Because spline regressions showed 
an approximately linear relation, we used a 
general   linear model (GLM) to examine the 
cadmium effect. Based on the literature and 
our previous work with these data (Bonithon-
Kopp et al. 1986; Chen et al. 2007; Marlowe 
et al. 1985a), a priori covariates included exact 
age at IQ measurement, treatment group, 
caregiver’s IQ, clinical center, single parent 
(yes or no), language (English or Spanish), 
race (non-Hispanic black or other), sex, par-
ents’ employment (neither working or either 
working), parents’ education (< 12 years, 12 
years, or > 12 years), and concurrent blood 
lead levels. The same set of covariates was 
included for the regression models at 2 years 
of age (except for treatment group) and at 5 
and 7 years of age. Treatment per se was not 
associated with cadmium, IQ, or behavior 
scores in GLM analyses (Dietrich et al. 2004; 
Rogan et al. 2001), and additional adjustment 
for treatment group did not markedly change 
the results; thus, the groups were combined in 
subsequent analyses.
The relationship between blood cadmium 
and blood pressure was examined by local 
polynomial regression—a nonparametric 
regression method that makes no assumptions 
about the functional form for the expected 
Figure 1. Comparison of blood cadmium levels (95% CIs) between TLC and NHANES children, based on the 
data from NHANES 2005–2006 (CDC 2009). The cadmium values for the 5th to 75th percentiles from NHANES 
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NHANES 2005–2006 (non-Hispanic black, 12–36 months)
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Table 1. Neuropsychological and behavioral test scores at ages 5 and 7 years of age by prepretreatment cadmium level.a
Cadmium level
< LODb LOD–0.22 µg/L 0.23–0.25 µg/L 0.26–0.32 µg/L ≥ 0.33 µg/L
Neuropsychological/behavioral test No. Mean ± SE No. Mean ± SE No. Mean ± SE No. Mean ± SE No. Mean ± SE
Age 5
NEPSY
Attention and executive 264 88 ± 1.8 88 85 ± 2.3 97 87 ± 2.3 84 86 ± 2.4 91 86 ± 2.3
Language 253 83 ± 1.9 88 82 ± 2.2 95 84 ± 2.3 80 84 ± 2.3 90 82 ± 2.3
Sensorimotor 267 90 ± 1.7 90 88 ± 2.1 99 89 ± 2.2 83 88 ± 2.2 96 90 ± 2.2
Visuospatial 270 93 ± 1.4 92 93 ± 1.7 102 95 ± 1.7 87 92 ± 1.8 99 92 ± 1.7
Memory 268 86 ± 1.7 90 86 ± 2.0 99 88 ± 2.1 82 87 ± 2.2 97 85 ± 2.1
CPRS-R
Oppositional index 285 63 ± 1.5 99 63 ± 1.9 104 64 ± 1.9 92 65 ± 1.9 103 65 ± 1.9
Hyperactivity index 285 66 ± 1.4 99 65 ± 1.8 104 66 ± 1.8 92 65 ± 1.9 103 65 ± 1.8
ADHD index 285 62 ± 1.4 99 64 ± 1.7 104 63 ± 1.7 92 60 ± 1.8 103 63 ± 1.7
Behavioral index 285 64 ± 1.3 99 64 ± 1.6 104 64 ± 1.6 92 63 ± 1.6 103 64 ± 1.6
Age 7
NEPSY
Attention and executive 226 89 ± 1.8 83 89 ± 2.3 85 92 ± 2.4 71 87 ± 2.5 91 88 ± 2.3
CPT d-Prime 213 55 ± 1.2 81 55 ± 1.4 84 54 ± 1.5 71 53 ± 1.5 89 56 ± 1.4
CVLTC
List A memory 245 41 ± 1.2 92 41 ± 1.5 94 44 ± 1.6* 79 41 ± 1.6 96 41 ± 1.6
Learning slope 245 –0.5 ± 0.1 92 –0.1 ± 0.2* 94 –0.3 ± 0.2 79 –0.3 ± 0.2 96 –0.4 ± 0.2
WLPB-R
Broad reading score 228 92 ± 2.1 85 93 ± 2.6 85 93 ± 2.7 72 91 ± 2.8 93 92 ± 2.6
CPT Hit response time 213 42 ± 1.5 81 44 ± 1.9 84 46 ± 1.9 71 40 ± 2.0 89 46 ± 1.9
NESS
Sequential movement time 213 1.1 ± 0.1 82 1.1 ± 0.2 82 0.9 ± 0.2 68 1.3 ± 0.2 66 1.0 ± 0.2
BASC-TRS
Adaptive skills 205 48 ± 1.1 71 47 ± 1.4 79 48 ± 1.6 65 48 ± 1.6 80 47 ± 1.5
Behavioral Symptoms Index 206 52 ± 1.4 76 51 ± 1.8 80 52 ± 1.8 68 52 ± 1.9 80 52 ± 1.8
Externalizing problems 205 52 ± 1.6 75 51 ± 2.0 81 51 ± 2.0 67 50 ± 2.1 81 53 ± 2.0
Internalizing problems 206 52 ± 1.2 76 51 ± 1.6 81 52 ± 1.6 68 51 ± 1.7 80 51 ± 1.6
School problems 206 55 ± 1.4 75 55 ± 1.8 81 55 ± 1.9 68 54 ± 2.0 81 55 ± 1.9
BASC-PRS
Adaptive skills 246 43 ± 1.2 92 42 ± 1.5 95 42 ± 1.5 79 43 ± 1.6 96 41 ± 1.5
Behavioral Symptoms Index 246 56 ± 1.7 92 56 ± 2.1 95 58 ± 2.2 79 55 ± 2.3 96 56 ± 2.2
Externalizing problems 246 59 ± 1.7 92 58 ± 2.1 95 60 ± 2.2 79 56 ± 2.3 96 58 ± 2.2
Internalizing problems 246 49 ± 1.4 92 50 ± 1.7 95 51 ± 1.8 79 51 ± 1.9 96 49 ± 1.8
ADHD, attention deficit–hyperactivity disorder.
aMeans are adjusted for treatment group, age, caregiver’s IQ, clinic center, single parent, language, race, sex, parent’s employment, parent’s education, and concurrent blood lead 
level. bLOD = 0.2 µg/L. *p < 0.05, pairwise test of specified cadmium level category versus the reference (< LOD) category.Postnatal cadmium exposure and child neurodevelopment
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value of a response given a regressor (Fan and 
Gijbels 1996).
All models were examined for statistical 
outliers and influential points. Each model 
was run first with outliers and then without 
outliers, and the results were compared. All 
of the results were essentially the same with or 
without outliers. Correlation and GLM anal-
yses were done by STATA software (version 
10.1; StataCorp., College Station, TX, USA) 
and SAS software (version 9.13; SAS Institute 
Inc., Inc., Cary, NC, USA).
Results
Of 780 children randomized in the parent 
study, 767 had sufficient pretreatment sample 
available for cadmium analysis. Six hundred 
eighty-three children had posttreatment sam-
ples, and 675 had sufficient sample available 
for cadmium analysis. Blood cadmium was 
detected and quantified in 441 (57%) pretreat-
ment samples and in 373 (55%) posttreatment 
samples. Pretreatment blood cadmium and 
lead levels were not correlated (ktau-b = 0.04, 
p = 0.11), which suggests that cadmium expo-
sure was independent of lead exposure.
For all children, the GMs and 95% con-
fidence intervals (CIs) of pre- and posttreat-
ment cadmium concentrations of placebo 
group were 0.21 µg/L (0.20–0.22 µg/L) and 
0.20 µg/L (0.19–0.21 µg/L), respectively; 
the GMs and 95% CIs of pre- and posttreat-
ment cadmium concentrations of succimer 
group were 0.21 µg/L (0.20–0.22 µg/L) and 
0.21 µg/L (0.20–0.22 µg/L), respectively. The 
censored regression analysis showed that there 
was no significant difference of cadmium con-
centrations between placebo group and succi-
mer group (p = 0.79 and p = 0.58 for pre- and 
posttreatment, respectively). These levels were 
lower than observed in National Health and 
Nutrition Examination Survey (NHANES) 
adults (GM = 0.41 µg/L; 95% CI, 0.38–
0.45 µg/L) (CDC 2005) but comparable to 
NHANES children < 3 years of age (Figure 1).
Table 1 shows scores for neuropsychological 
and behavioral tests by cadmium levels at 5 and 
7 years of age. Not all children completed all 
tests, so the sample sizes vary slightly. For each 
outcome domain of a specific test instrument, 
cadmium categories with measureable levels 
were compared with the reference (< LOD) 
category. Except for the list A memory and 
learning slope (the positive learning slope over 
five verbal memory recall trials, with the steeper 
positive value the more favorable indicator of 
learning) of CVLTC, these test scores did not 
differ among cadmium categories.
After excluding the nondetectables, the 
neuropsychological and behavioral test scores 
still did not show significant associations 
with blood cadmium concentration (data not 
shown). Although not statistically significant, 
the four-knot cubic spline regression analysis 
showed that in the models with behavioral 
problem scores, both the first-order coefficient 
and the third-order coefficient of blood cad-
mium were positive, and the absolute value of 
the third-order coefficient was larger than the 
absolute value of the second-order coefficient 
(data not shown), which suggests that behav-
ioral problem scores at 5 and 7 years of age 
tend to increase (which indicates worse behav-
ior) with increasing blood cadmium. When 
three extreme cadmium values were omitted, 
the trend persisted in results at 7 years of age 
(Figure 2).
Table 2 shows the baseline and follow-up 
demographic characteristics for children with 
detectable pretreatment blood cadmium. 
Except for 1-µg/dL differences in blood lead 
levels at 5 and 7 years of age, the two groups 
did not differ and so were combined. We plot-
ted blood cadmium and MDI at 2 years of age 
and IQ at 5 and 7 years of age and did spline 
regression. MDI showed a weak increasing 
trend by cadmium levels, but at 5 and 7 years 
of age IQ showed a weak decreasing trend by 
cadmium levels (data not shown). Based on 
the approximately linear relationship, we con-
ducted GLM analyses of cadmium and MDI 
or IQ at 2, 5, and 7 years of age adjusting for 
a variety of covariates. The pretreatment cad-
mium level and posttreatment cadmium level 
were significantly correlated with each other 
(ktau-b = 0.45), so we used pretreatment cad-
mium level as the main independent variable 
in GLM analyses. In the GLM models, the 
coefficient of cadmium was positive at 2 years 
but negative at 5 and 7 years of age, but none 
of the coefficients was statistically significant 
(Table 3). GLM analyses were repeated after 
excluding three extreme cadmium values, and 
the results were very similar.
For blood pressure, because no differ-
ences between succimer and placebo groups at 
baseline and other time points were observed 
(Chen et al. 2006), we combined the two 
groups to analyze the association between 
blood cadmium and blood pressure. When 
treatment began, the mean (± SD) systolic 
and diastolic blood pressures of children 
with detectable blood cadmium were 100.3 
± 12.4 mmHg and 59.5 ± 10.1 mmHg, 
respectively. There was a significant (p = 0.03) 
1.7-mmHg decrement of the mean systolic 
blood pressure at 1 week after treatment 
began, which might be attributable to the sig-
nificantly decreased blood lead level, but the 
mean diastolic blood pressure did not change 
after treatment. We then plotted the cross-
sectional association of blood cadmium level 
and blood pressure of children with detectable 
blood cadmium with data from pretreatment, 
posttreatment, and 5 and 7 years of age, along 
with local polynomial regression predictions 
(Figure 3). We found no clear association 
between pre- or posttreatment blood cad-
mium level and blood pressure at these ages.
Discussion
Using data from a large clinical trial of chil-
dren with moderately high lead exposure, we 
examined the association between cadmium 
Figure 2. Scatterplots and smoothed spline regression curves of pretreatment blood cadmium (BCd) con-
centrations and parent-rated BASC test scores at 7 years of age: PADP (A), PBSI (B), PEXT (C), and PINTR 
(D) denote parent-rated BASC scores of adaptive skills, behavioral symptoms index, externalizing prob-
lems, and internalizing problems, respectively. 
PADP by BCd (pretreatment)
PEXT by BCd (pretreatment) PINTR by BCd (pretreatment)
Blood cadmium at pretreatment (µg/L)
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exposure and neurodevelopment in children. 
TLC children had blood cadmium levels com-
parable to those of children of the same age 
in a representative sample of the general U.S. 
population but significantly lower than lev-
els of the adults in the same national sample. 
Because cigarette smoke is a major source of 
cadmium exposure, and these TLC children 
are exposed only to passive smoking, this lower 
concentration was expected. We did not find 
a significant relationship between blood cad-
mium level and IQ or neuropsychological and 
behavioral test scores after adjusting for lead 
levels and other potentially confounding vari-
ables. Although the estimates of behavioral 
test scores of CPRS-R at 5 years of age and 
of BASC behavioral problems (both teacher 
and parent rated) at 7 years of age were not 
significantly associated with detectable blood 
cadmium level, we did find that behavioral 
problems tended to increase with increasing 
blood cadmium concentrations at 7 years of 
age. At the most, this suggests that cadmium 
exposure at 2 years of age may have some small 
neurodevelopmental effect later when a wider 
range of behavioral issues can be examined, 
especially with higher or longer exposure.
The commercial use of cadmium has 
declined in developed countries in response to 
environmental concerns. In the United States, 
the GM daily cadmium intake is about 0.4 µg/
kg/day, less than half of the U.S. EPA’s oral 
reference dose (U.S. EPA 2006). Cadmium, 
however, has a long biological half-life, so even 
Table 2. Baseline and follow-up characteristics of enrolled children with detectable pretreatment 
  cadmium.
Characteristic Placebo (n = 223) Succimer (n = 218) p-Value
Age [years (mean ± SD)] 2.1 ± 0.4 2.1 ± 0.4 p = 0.59a
Weight [kg (mean ± SD)] 12.4 ± 1.8 12.7 ± 2.0 p = 0.07a
Height [cm (mean ± SD)] 86.4 ± 5.2 86.8 ± 5.6 p = 0.43a
Body surface area [m2 (mean ± SD)] 0.5 ± 0.1 0.5 ± 0.1 p = 0.12a
Clinic center [no. (%)] p = 0.87b
Baltimore 54 (24) 56 (26)
Newark 49 (22) 53 (24)
Philadelphia 53 (24) 50 (23)
Cincinnati 67 (30) 59 (27)
Ethnic group or race [no. (%)] p = 0.75b
White 24 (11) 27 (12)
Non-Hispanic black 177 (79) 173 (79)
Other 22 (10) 18 (9)
Female sex [no. (%)] 99 (44) 93 (43) p = 0.71b
English-speaking [no. (%)] 217 (97) 210 (96) p = 0.56b
Parent’s education [years; no. (%)] p = 0.62b
< 12  84 (38) 92 (42)
12 103 (46) 94 (43)
> 12 36 (16) 32 (15)
Neither parent working [no. (%)] 132 (59) 138 (63) p = 0.38b
Living with single parent [no. (%)] 162 (74) 160 (74) p = 0.98b
IQ score (mean ± SD)
MDI (analogous to 2-year IQ) 80.9 ± 12.9 (n = 217) 81.5 ± 13.8 (n = 217) p = 0.67a
5-year IQ 80.7 ± 12.7 (n = 209) 79.8 ± 13.3 (n = 204) p = 0.48a
7-year IQ 86.6 ± 13.4 (n = 195) 85.9 ± 12.9 (n = 178) p = 0.62a
Blood cadmium [µg/L; GM (95% CI)]
Pretreatment 0.28 (0.27–0.29) 0.29 (0.28–0.30) p = 0.20c
Posttreatment 0.22 (0.21–0.24) (n = 189) 0.24 (0.22–0.26) (n = 184) p = 0.11c
Blood lead [µg/dL (mean ± SD)]
Baseline 26.1 ± 5.0 26.7 ± 5.7 p = 0.62a
5 year  12.0 ± 4.7 (n = 210) 13.1 ± 5.3 (n = 206) p = 0.02a
7 yeard 7.9 ± 3.7 (n = 195) 8.9 ± 4.2 (n = 172) p = 0.02a
aMeans were compared by t-test. bProportions were compared by Pearson chi-square test. cDistributions were com-
pared by Wilcoxon rank-sum test. dOne child with a blood lead concentration of 50.8 µg/dL was excluded from the 
analysis.
Table 3. GLM regression coefficients of cadmiuma and covariates on IQ at baseline and follow-up.
Independent variable
MDI IQ at 5 years of age IQ at 7 years of age
Coefficient 95% CI Coefficient 95% CI Coefficient 95% CI
Pretreatment cadmium (µg/L, ln) 3.5 –0.1 to 7.0 –1.9 –5.5 to 1.6 –2.2 –6.0 to 1.7
Treatment group –0.5 –2.9 to 1.9 –0.1 –2.6 to 2.4
Exact age at IQ measurement (years) –5.4 –8.4 to –2.4* –3.2 –5.8 to –0.6* 3.6 –5.9 to 13.2
Caregiver’s IQ  0.3 0.2 to 0.4* 0.4 0.2 to 0.5b 0.4 0.3 to 0.5*
Center 
Baltimore Reference
Newark –1.5 –5.3 to 2.2 –5.6 –9.2 to –2.1* 1.0 –3.1 to 5.1
Philadelphia –1.7 –5.4 to 1.9 1.8 –1.7 to 5.3 6.2 2.0 to 10.5*
Cincinnati –4.9 –8.5 to –1.4* –4.8 –8.2 to –1.3* –2.3 –6.4 to 1.9
Living with single parent
No Reference
Yes 2.0 –1.3 to 5.3 0.7 –2.5 to 3.9 0.3 –3.0 to 3.7
Language
English Reference
Spanish 1.3 –7.1 to 9.6 0.4 –7.5 to 8.2 –5.2 –12.8 to 2.4
Race
Non-Hispanic black  Reference
Others 1.7 –2.0 to 5.4 1.2 –2.4 to 4.7 3.0 –0.7 to 6.7
Sex
Male Reference
Female 2.7 0.2 to 5.2* –0.6  –3.0 to 1.8 –0.6 –3.0 to 1.9
Neither parent working
Yes Reference
No –0.1 –3.2 to 2.9 –0.2 –3.1 to 2.7 0.9 –2.1 to 3.9
Parent’s education (years)
< 12 –0.1 –2.9 to 2.8 –1.0 –3.7 to 1.8 –0.5 –3.3 to 2.3
12 Reference
> 12 –0.8 –4.5 to 3.0 –0.4 –4.0 to 3.2 2.6 –1.1 to 6.4
Concurrent lead level (µg/dL) –0.3 –0.5 to –0.1* –0.4 –0.6 to –0.1* –0.3 –0.6 to –0.1*
aIncludes only detectable values. *p < 0.05.Postnatal cadmium exposure and child neurodevelopment
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low doses may bioaccumulate and lead to sig-
nificant adverse effects if exposure continues 
for a long period of time. Animal experiments 
showed that cadmium’s most direct effect on 
brain metabolism is to inhibit a number of 
sulfhydryl-containing enzymes (Stowe et al. 
1972). Consequently, chronic exposure to 
cadmium has a depressive effect on levels of 
norepinephrine, serotonin, and acetylcholine 
(Singhal et al. 1976; Webb 1975). Animal 
studies also demonstrated cadmium transport 
through the immature blood–brain barrier 
of suckling rat pups (Andersson et al. 1997). 
Although there are few reports on blood–
brain barrier and cadmium in human samples, 
there has been a single case report of cadmium 
encephalopathy in a 2-year-old child, support-
ing the notion that the blood–brain barrier 
does not prevent entry of cadmium in early 
childhood (Provias et al. 1994). This evidence 
suggests that neurobehavioral effects during 
development may also be a sensitive end point 
for cadmium toxicity in addition to renal dys-
function (Petersson-Grawe et al. 2004).
In the 1970s and 1980s, there were several 
studies of cadmium and child neuropsycho-
logical performance. Based on hair samples 
from 31 learning disabled and 22 normal 
children, Pihl and Parkes (1977) found that 
concentrations of cadmium, cobalt, manga-
nese, chromium, and lithium could classify 
subjects as learning disabled or normal with 
98% accuracy. Our study did not identify 
children specifically as “learning disabled,” 
but we found no association between cad-
mium and IQ or behavior problems, which 
are often components of learning disability. 
Hair measures are subject to contamination; 
if the behavior of the “learning disabled” chil-
dren leads to contamination, then the finding 
may be attributable to reverse causality. Capel 
et al. (1981) found higher cadmium levels 
in the hair of 73 dyslexic children than in 44 
controls. However, these researchers measured 
nine elements without any specific hypoth-
eses, found several differences, but interpreted 
their findings as preliminary and in need of 
confirmation. Thatcher et al. (1982) reported 
that hair cadmium in 149 children 5–16 years 
of age was related to intelligence tests, motor 
function, and school achievement and found 
that cadmium had a stronger effect on verbal 
IQ than did lead. Although these researchers 
used statistical modeling to control confound-
ing due to race, rural residence, and simultane-
ous lead exposure, the potential for substantial 
residual confounding remains with this rela-
tively small data set. Bonithon-Kopp et al. 
(1986) analyzed hair samples from 26 new-
born babies and found a significant negative 
relationship between the prenatal cadmium 
exposure and child’s motor and perceptual 
abilities at 6 years of age. These research-
ers did not collect information on maternal 
smoking, which is a source of cadmium expo-
sure and is also associated with child’s IQ 
(Alati 2008). Marlowe et al. (1983) found 
an association between elevated cadmium 
concentrations and mild mental retardation 
and borderline intelligence in 135 children. 
Another study conducted by Marlowe at al. 
(1985a) in 80 randomly selected elementary-
age children showed synergistic interaction of 
lead with cadmium related to increased scores 
on acting-out, disturbed peer relations, and 
immaturity on the Walker Problem Behavior 
Identification Checklist. These studies are 
cross-sectional, and it is difficult to dismiss the 
possibility that some aspect of the children’s 
behavior led to their exposure.
All of the above-mentioned studies are 
case–control or cross-sectional in design, and 
confounding from other substances (i.e., 
lead exposure) cannot be excluded entirely. 
Moreover, in previous studies on cadmium 
exposure and child neurodevelopment, none of 
them measured blood cadmium levels but used 
the concentration of cadmium in hair. Although 
hair has been used widely in metals exposure 
studies as an easily accessible material for esti-
mating an accumulated metals body burden, a 
major criticism of hair analysis is the wide inter-
laboratory variation in the results (ATSDR and 
CDC 2001; Capel et al. 1981), and it may not 
reflect the appropriate exposure averaging time 
for the outcomes evaluated. Because cadmium 
enters the blood quickly and has an extremely 
long biological half-life (ATSDR 1999), it is 
reasonable to assume that blood concentrations 
reflect both recent and cumulative exposures 
(CDC 2005; Hassler et al. 1983).
Our study has the strength of large sample 
size, direct cadmium exposure measurement 
in blood, long follow-up period, high reten-
tion rate of subjects in the follow-up, multiple 
measurements of behavior and cognition, and 
good quality control in the measurements. The 
longitudinal nature of the data also allowed 
us to take a prospective view on the associa-
tion between postnatal cadmium exposure and 
child neurodevelopment.
Study limitations include lack of cad-
mium measurement at 5 and 7 years of age. 
According to the results based on NHANES 
data, blood cadmium concentration increases 
with age (CDC 2005). Further research is 
needed to better understand the effects of 
concurrent and cumulative cadmium expo-
sure on children’s cognitive and behavior.
We also examined the association between 
blood pressure and low-level cadmium expo-
sure. Cadmium induces hypertension in ani-
mal models, and the potential mechanism 
is hypothesized to be related to kidney dys-
function (Satarug et al. 2006). Epidemiologic 
studies, however, of environmental cadmium 
exposure and blood pressure are not consis-
tent, and no epidemiologic study on children 
has measured both blood cadmium and blood 
pressure levels. In our study, we find no rela-
tion between a background cadmium exposure 
and blood pressure, but a potential hyperten-
sive effect from longer background exposures 
needs further study.
Figure 3. Scatterplots [and local polynomial regression predictions (with 95% CI)] of systolic and diastolic 
blood pressure for pretreatment (A), posttreatment (B), 5 years of age (C), and 7 years of age (D) by detect-
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